Approved Use: Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including: allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for the full Prescribing Information and Patient Product Information.

APPROVED USE

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

paying for Aimovig®

cost of Aimovig and
access support options

The list price of Aimovig® is $575 per month.* Most patients do not pay the list price. Your actual cost will vary. Talk to your insurance provider.

We have resources that can help. Eligible commercially insured patients can get Aimovig free for up to 12 doses or $5 copay per month.

Program details:

With the Aimovig Ally Access Card, an eligible commercially insured patient can receive one of the following two offers:

  • If the patient’s health plan does not cover Aimovig® (erenumab-aooe) or requires a prior authorization, the patient can receive Aimovig® free for up to 12 doses over 24 months from the date of the first prescription filled under the Bridge to Commercial Coverage Offer. See full Terms and Conditions below.
  • If Aimovig® is approved by the patient’s health plan, a patient pays a $5 copay per month, up to a maximum benefit of $2700 annually. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Aimovig®. Patient is responsible for costs above the annual maximum. See full Terms and Conditions below.

Terms and Conditions for Bridge to Commercial Coverage Offer (“Bridge Offer”) – Aimovig® free for up to 12 doses over 24 months (whichever occurs first) from the first prescription filled under the Bridge Offer: Patient must be prescribed Aimovig® and have previously failed another preventive migraine treatment. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. By participating in this offer, patient acknowledges intent to pursue insurance coverage for Aimovig® with their healthcare provider. Ongoing eligibility requires that patient has (i) a prior authorization or medical exception denied within 90 days of first use of offer, and (ii) an appeal of the prior authorization or medical exception denied within 180 days of first use of offer. Once insurance approval is obtained, patient is no longer eligible for this offer. No purchase necessary. This is not health insurance. Participation is not a guarantee of insurance coverage. This offer is not renewable. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice.

Terms and Conditions for Copay Offer: Pay a $5 copay per month, up to a maximum benefit of $2700 annually. Patient must be prescribed Aimovig®. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. Patient may not seek reimbursement for value received from this offer from any third-party payers, including flexible spending accounts or healthcare savings accounts. This is not health insurance. Participation is not a guarantee of insurance coverage. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice. If you become aware that your health plan or pharmacy benefit manager does not allow the use of manufacturer copay support as part of your health plan design, you agree to comply with your obligations, if any, to disclose your use of the card to your insurer. This offer is ongoing and in order to remain eligible, patient must re-enroll every 12 months by visiting www.aimovigaccesscard.com/ or by calling 833-AIMOVIG (833-246-6844).

if you have private or commercial insurance

For eligible commercially insured patients

Aimovig free for up to 12 doses

or

$5 copay per month

Sample of access card

Program details:

With the Aimovig Ally Access Card, an eligible commercially insured patient can receive one of the following two offers:

  • If the patient’s health plan does not cover Aimovig® (erenumab-aooe) or requires a prior authorization, the patient can receive Aimovig® free for up to 12 doses over 24 months from the date of the first prescription filled under the Bridge to Commercial Coverage Offer. See full Terms and Conditions below.
  • If Aimovig® is approved by the patient’s health plan, a patient pays a $5 copay per month, up to a maximum benefit of $2700 annually. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Aimovig®. Patient is responsible for costs above the annual maximum. See full Terms and Conditions below.

Terms and Conditions for Bridge to Commercial Coverage Offer (“Bridge Offer”) – Aimovig® free for up to 12 doses over 24 months (whichever occurs first) from the first prescription filled under the Bridge Offer: Patient must be prescribed Aimovig® and have previously failed another preventive migraine treatment. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. By participating in this offer, patient acknowledges intent to pursue insurance coverage for Aimovig® with their healthcare provider. Ongoing eligibility requires that patient has (i) a prior authorization or medical exception denied within 90 days of first use of offer, and (ii) an appeal of the prior authorization or medical exception denied within 180 days of first use of offer. Once insurance approval is obtained, patient is no longer eligible for this offer. No purchase necessary. This is not health insurance. Participation is not a guarantee of insurance coverage. This offer is not renewable. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice.

Terms and Conditions for Copay Offer: Pay a $5 copay per month, up to a maximum benefit of $2700 annually. Patient must be prescribed Aimovig®. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. Patient may not seek reimbursement for value received from this offer from any third-party payers, including flexible spending accounts or healthcare savings accounts. This is not health insurance. Participation is not a guarantee of insurance coverage. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice. If you become aware that your health plan or pharmacy benefit manager does not allow the use of manufacturer copay support as part of your health plan design, you agree to comply with your obligations, if any, to disclose your use of the card to your insurer. This offer is ongoing and in order to remain eligible, patient must re-enroll every 12 months by visiting www.aimovigaccesscard.com/ or by calling 833-AIMOVIG (833-246-6844).

Sample of access card

If the patient’s health plan does not cover Aimovig® or requires a prior authorization, the patient can qualify for the Bridge to Commercial Coverage offer and receive Aimovig® free for up to 12 doses over 24 months from their first fill, while pursuing approval from their health plan. No purchase necessary. .

Program details:

With the Aimovig Ally Access Card, an eligible commercially insured patient can receive one of the following two offers:

  • If the patient’s health plan does not cover Aimovig® (erenumab-aooe) or requires a prior authorization, the patient can receive Aimovig® free for up to 12 doses over 24 months from the date of the first prescription filled under the Bridge to Commercial Coverage Offer. See full Terms and Conditions below.
  • If Aimovig® is approved by the patient’s health plan, a patient pays a $5 copay per month, up to a maximum benefit of $2700 annually. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Aimovig®. Patient is responsible for costs above the annual maximum. See full Terms and Conditions below.

Terms and Conditions for Bridge to Commercial Coverage Offer (“Bridge Offer”) – Aimovig® free for up to 12 doses over 24 months (whichever occurs first) from the first prescription filled under the Bridge Offer: Patient must be prescribed Aimovig® and have previously failed another preventive migraine treatment. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. By participating in this offer, patient acknowledges intent to pursue insurance coverage for Aimovig® with their healthcare provider. Ongoing eligibility requires that patient has (i) a prior authorization or medical exception denied within 90 days of first use of offer, and (ii) an appeal of the prior authorization or medical exception denied within 180 days of first use of offer. Once insurance approval is obtained, patient is no longer eligible for this offer. No purchase necessary. This is not health insurance. Participation is not a guarantee of insurance coverage. This offer is not renewable. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice.

Terms and Conditions for Copay Offer: Pay a $5 copay per month, up to a maximum benefit of $2700 annually. Patient must be prescribed Aimovig®. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. Patient may not seek reimbursement for value received from this offer from any third-party payers, including flexible spending accounts or healthcare savings accounts. This is not health insurance. Participation is not a guarantee of insurance coverage. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice. If you become aware that your health plan or pharmacy benefit manager does not allow the use of manufacturer copay support as part of your health plan design, you agree to comply with your obligations, if any, to disclose your use of the card to your insurer. This offer is ongoing and in order to remain eligible, patient must re-enroll every 12 months by visiting www.aimovigaccesscard.com/ or by calling 833-AIMOVIG (833-246-6844).

If approved by the patient’s health plan to take Aimovig® , a patient pays a $5 copay per month, up to a maximum benefit of $2700 annually. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Aimovig® . .

Program details:

With the Aimovig Ally Access Card, an eligible commercially insured patient can receive one of the following two offers:

  • If the patient’s health plan does not cover Aimovig® (erenumab-aooe) or requires a prior authorization, the patient can receive Aimovig® free for up to 12 doses over 24 months from the date of the first prescription filled under the Bridge to Commercial Coverage Offer. See full Terms and Conditions below.
  • If Aimovig® is approved by the patient’s health plan, a patient pays a $5 copay per month, up to a maximum benefit of $2700 annually. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Aimovig®. Patient is responsible for costs above the annual maximum. See full Terms and Conditions below.

Terms and Conditions for Bridge to Commercial Coverage Offer (“Bridge Offer”) – Aimovig® free for up to 12 doses over 24 months (whichever occurs first) from the first prescription filled under the Bridge Offer: Patient must be prescribed Aimovig® and have previously failed another preventive migraine treatment. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. By participating in this offer, patient acknowledges intent to pursue insurance coverage for Aimovig® with their healthcare provider. Ongoing eligibility requires that patient has (i) a prior authorization or medical exception denied within 90 days of first use of offer, and (ii) an appeal of the prior authorization or medical exception denied within 180 days of first use of offer. Once insurance approval is obtained, patient is no longer eligible for this offer. No purchase necessary. This is not health insurance. Participation is not a guarantee of insurance coverage. This offer is not renewable. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice.

Terms and Conditions for Copay Offer: Pay a $5 copay per month, up to a maximum benefit of $2700 annually. Patient must be prescribed Aimovig®. Available if patient is commercially insured and 18 years or older. This offer is not valid if patient is uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, the Retiree Drug Subsidy Program, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE or where prohibited by law. Cash Discount Cards and other noninsurance plans are not valid as primary under this offer. If at any time patient begins receiving coverage under any such federal-, state-, or government-funded healthcare program, patient will no longer be able to use this offer and patient must call 833-AIMOVIG to stop participation. Patient may not seek reimbursement for value received from this offer from any third-party payers, including flexible spending accounts or healthcare savings accounts. This is not health insurance. Participation is not a guarantee of insurance coverage. Valid in the United States, Puerto Rico, and the US territories. Other restrictions may apply. This offer is subject to change or discontinuation without notice. If you become aware that your health plan or pharmacy benefit manager does not allow the use of manufacturer copay support as part of your health plan design, you agree to comply with your obligations, if any, to disclose your use of the card to your insurer. This offer is ongoing and in order to remain eligible, patient must re-enroll every 12 months by visiting www.aimovigaccesscard.com/ or by calling 833-AIMOVIG (833-246-6844).

Over 75,000 people
have enrolled with the
Aimovig Ally Access Card

get Aimovig at your favorite pharmacy§

Have questions?

Call our Aimovig Ally support team at 833-AIMOVIG (833-246-6844), Monday - Friday, 8 am - 8 pm ET.

back to top

if you have Medicare or Medicaid

Patients with Medicare or Medicaid may be eligible for
Aimovig coverage under their health insurance plan. To find out if you’re covered, call your insurance provider today.

Medicare Medicare
Medicaid Medicaid
back to top

if you’re not insured

The Amgen Safety Net Foundation is an independent, nonprofit patient assistance program that provides Aimovig® at no cost to qualifying patients who have a financial need and who are uninsured or have insurance that excludes Aimovig.

back to top

Aimovig Ally support

Our support team is your ally. We're here to help you get started by answering questions and providing resources.

  • We offer supplemental injection overview videos and resources to help you use Aimovig
  • Call us at 833-AIMOVIG (833-246-6844), Monday - Friday, 8 am - 8 pm ET
  • Sign up for helpful resources and educational materials today
contact us here 1-833-AIMOVIG (1-833-246-6844)
8 AM-8 PM ET, Mon-Fri

IMPORTANT SAFETY INFORMATION

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including: allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for the full Prescribing Information and Patient Product Information.

APPROVED USE

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.